美国生物技术公司Akero Therapeutics(AKRO.US)涨约16.5%,报54.15美元。消息面上,诺和诺德同意以高达52亿美元的价格收购Akero Therapeutics,旨在获取后者一款前景广阔的肝病药物。现金预付款为每股54美元,较Akero周三收盘价溢价约16%。(格隆汇)
美国生物技术公司Akero Therapeutics(AKRO.US)涨约16.5%,报54.15美元。消息面上,诺和诺德同意以高达52亿美元的价格收购Akero Therapeutics,旨在获取后者一款前景广阔的肝病药物。现金预付款为每股54美元,较Akero周三收盘价溢价约16%。(格隆汇)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.